Maheen Adamson

Advisor at Polaris Genomics

Dr. Maheen Mausoof Adamson (VA) completed her Ph.D. in neuroscience from the University of Southern California & a postdoctoral fellowship in psychiatry & behavioral sciences at Stanford School of Medicine. Dr. Adamson has over 15 years of experience directing multi-site & longitudinal studies on Alzheimer’s disease & brain injuries, especially in the veteran population. She currently leads several federally-funded studies (DOD, NIA/NIH, & VA) investigating neuroimaging, genetics, proteomics, & behavioral performance in the rehabilitation of healthy older adults & veterans with post-deployment health concerns. An internationally recognized expert on the cognitive & neural basis of Alzheimer’s disease & TBI, Dr. Adamson has authored numerous peer-reviewed publications on the subject, & has served as former senior editor of Journal of Alzheimer’s Disease & co-editor of Frontiers in Neurology: TBI. She currently serves as Clinical Senior Scientific Research Director for Rehabilitation Service at VAPAHCS, & has served as Director for Research and Ph.D. Fellowships at the War Related Illness & Injury Center (WRIISC), & Director of Research for the Defense & Veterans Brain Injury Center (DVBIC). She also co-chairs the TBI committee at the California Department of Rehabilitation; nominated member of the Sigma Xi society; program committee member of the American Congress of Rehabilitation Medicine; & board member of the Brain Injury Association of California & Society for Brain Mapping & Therapeutics. Dr. Adamson recently completed the Stanford Byer’s Biodesign Faculty Innovation Fellowship & is currently enrolled in the Masters of Science in Healthcare Leadership program at Brown University’s School of Professional Studies.

Location

San Francisco, United States

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Polaris Genomics

At the junction of precision medicine and behavioral health, Polaris Genomics has a vision to reduce suicide, stigma, and suffering in silence.


Industries

Employees

11-50

Links